Actualités sur Enterprises

Suivre
Abonner Enterprises
Filtre
  • 12.05.2010 – 16:09

    Glitnir Bank

    Glitnir Bank Files US$2bn Legal Claim Against Jón Ásgeir Jóhannesson and Other Former Directors and Shareholders, Alleging Fraud; also Sues PwC for Malpractice and Negligence

    New York, May 12, 2010 (ots/PRNewswire) - Glitnir Bank announces that it has commenced legal action in the Supreme Court of the State of New York against Jón Ásgeir Jóhannesson, formerly its principal shareholder, Lárus Welding, previously Glitnir's Chief Executive, Thorsteinn Jonsson, its former Chairman, ...

  • 12.05.2010 – 13:31

    Algorithme Pharma

    Algorithme Pharma Announces a Strategic Appointment

    Laval, Canada, May 12, 2010 (ots/PRNewswire) - Doug Peel, Executive Chairman of the Board of Directors of Algorithme Pharma, is pleased to announce the appointment of Christopher Perkin as the company's President and Chief Executive Officer. Mr. Perkin will officially join the company on May 31st. This important appointment confirms Algorithme Pharma's commitment to the development of innovative strategies to ...

  • 12.05.2010 – 08:07

    sanofi-aventis Group

    Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent Atrial Fibrillation

    Paris, May 12, 2010 (ots/PRNewswire) - Sanofi-aventis announced today the initiation of a multinational, randomized, double-blind Phase IIIb trial, PALLAS, to assess the potential clinical benefit of Multaq(R) (dronedarone) in over 10,000 patients with permanent atrial fibrillation (AF) to reduce major adverse cardiovascular events. The announcement was made during ...

  • 12.05.2010 – 08:00

    WISeKey SA

    WISeKey and Original1 join forces to provide Global Brand Protection Services

    Geneva-Frankfurt (ots) - WISeKey and Original1 announce a strategic alliance for the usage of cryptography technologies in the field of anti-counterfeiting. The combination of strong authentication, with product lifecycle management services, as well as identification technologies, such as barcodes, RFIDs, holograms and other machine-readable marker ...

  • 11.05.2010 – 10:20

    Amsterdam Commodities NV

    Acomo Acquires Leading Position in Worldwide Tea and Seeds Trade

    Rotterdam, Netherlands, May 11, 2010 (ots/PRNewswire) - Amsterdam Commodities N.V. (Acomo) has reached an agreement with N.V. Deli Maatschappij (Deli) to buy its tea and seeds businesses for a total consideration of about EUR 100 million. The trading house specialized in spices, nuts and food ingredients is doubling its size. By taking over the Van Rees Group en Red River Group of companies, Acomo is acquiring a ...

  • 10.05.2010 – 18:08

    ICS Copper Systems Ltd

    ICS Re-assesses Opportunities

    Abbotsford, Canada, May 10, 2010 (ots/PRNewswire) - With reference to the company's previous News Release 10-02, ICS is pleased to announce that further to the withdrawal of JVC/Chantete from the JV with ICS, the company has reached a final settlement agreement with JVC/Chantete whereby the encumbered loan granted to ICS by JVC in the sum of USD $125,000, was fully settled by ICS. We are pleased to have reached an agreement and the removal of the encumbrance of ICS ...

  • 10.05.2010 – 08:02

    Chivas Regal

    Chivalry Goes Digital, Thanks to Chivas!

    London, May 10, 2010 (ots/PRNewswire) - Chivas Regal, the world's leading premium Scotch whisky, today announced the launch of a specifically created digital module, http://chivaspresscannes.com, which will serve as the international centre-point for the brand's ambitious 'Live with Chivalry' movement during the 63rd Cannes International Film Festival. A global media support tool, the site will be updated regularly ...

  • 07.05.2010 – 15:16

    Hoya Corporation

    Hoya Announces Fourth Quarter and Full-Year Financial Results

    Tokyo, May 7, 2010 (ots/PRNewswire) - HOYA Corporation today announced financial results for the fourth quarter and fiscal year ended March 31, 2010. Net sales were 104.8 billion yen for the quarter, representing an increase of 26.4% from 82.9 billion yen in the same period last year, mainly due to a recovery in orders in the main business fields such as Electro-Optics, as well as the cost-reduction achieved through ...

  • 07.05.2010 – 09:02

    eyeforpharma

    Managing Uncertainty; a Migraine for Pharma Forecasters

    London, May 7, 2010 (ots/PRNewswire) - Forecasting in pharmaceuticals has its up's and down's, with new markets and products proving more complex and requiring sophisticated approaches to forecast these areas. Dealing with uncertainties is no easy task. With a number of risks to consider, pharmaceutical forecasting teams need to be able to recognise commercial uncertainties surrounding a given product, capture it ...

  • 05.05.2010 – 20:56

    Avanti Mining Inc

    Avanti Mining Announces Dissemination of its CEO TV Interview

    Vancouver, May 5, 2010 (ots/PRNewswire) - (Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.) Avanti Mining Inc. is pleased to announce that Craig Nelsen, President & CEO of the Company appeared on a recent episode of resourceINTELLIGENCE TV. Mr. ...

  • 04.05.2010 – 14:00

    Royal dutch shell plc

    Shell Singapore: Meeting Asia's Growing Demand for Petrochemicals

    The Hague, The Netherlands, May 4, 2010 (ots/PRNewswire) - Shell's largest integrated refinery and petrochemicals complex is now fully online. The multi-billion dollar project in Singapore boosts the supply of raw materials for many everyday products and uses ultra-efficient Shell technology. The site is already supplying products to Asian growth markets and to manufacturers in Singapore. It is a cornerstone of ...

  • 04.05.2010 – 10:10

    Wyplay

    WYPLAY Secures 9 Million Euro Third Round Financing

    Marseille, France, May 4, 2010 (ots/PRNewswire) - WYPLAY SAS, a pioneer in the development of the High-Definition Media Center, today announced it has closed a 9 million euro third round of financing. Amundi Private Equity Funds, who led this 3rd round, was joined by A Plus Finance, Elaia Partners and Sofinnova Partners, Wyplay's second round lead investors reflecting their continued confidence in the company. ...

  • 03.05.2010 – 06:03

    EvaluatePharma Ltd

    Pfizer Reigns Supreme After Patent Cliff as Humira Kicks Avastin off Top Spot

    London, May 3, 2010 (ots/PRNewswire) - The rheumatoid arthritis treatment Humira will replace Lipitor as the world's biggest-selling drug in 2016, but a familiar name, Pfizer, will still be the biggest seller of medicines after the patent cliff according to the World Preview 2016 report published today by EvaluatePharma, the premier provider of pharma and biotech ...

  • 30.04.2010 – 14:16

    Celtic Pharmaceutical Holdings L.P.

    Celtic Pharma Announces Initiation of Phase III Trial of TDT 067 for the Treatment of Onychomycosis

    London, New York and Hamilton, Bermuda, April 30, 2010 (ots/PRNewswire) -- Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma"), the global private equity firm focused on the biotechnology and pharmaceutical industries, announced today the enrolment of the first patient into its Phase III trial of TDT 067, terbinafine in Transfersomes(R), for the topical treatment ...

  • 29.04.2010 – 17:32

    Agendia B.V.

    New Study Demonstrates Patients With High-Risk MammaPrint Profile Benefit From Chemotherapy

    HUNTINGTON BEACH, California, and AMSTERDAM, April 29, 2010 (ots/PRNewswire) -- Today, at the 11th Annual Meeting of the American Society of Breast Surgeons, Agendia, a world leader in molecular cancer diagnostics, announced that Breast Cancer Research and Treatment has published an important study demonstrating the benefit of adjuvant chemotherapy for patients with ...

  • 29.04.2010 – 14:02

    Aon Consulting EMEA

    European Workers Would Trade Money for an Early Retirement

    Rotterdam, The Netherlands, April 29, 2010 (ots/PRNewswire) - The lure of retirement is simply too much for many Europeans with almost one in three workers (29%) saying they would prefer their government not to raise the national retirement age, and would be happy to have less income in retirement, according to Aon Consulting, the leading employee risk and benefits management firm. This research is part of the Aon ...

  • 26.04.2010 – 12:00

    Helsinn Healthcare SA

    Helsinn and Vifor Pharma sign new contract for Gelclair in Switzerland

    Lugano (ots) - New therapeutic option for the management of painful symptoms of oral mucositis in the oncology setting soon available for Swiss patients Helsinn, the pharmaceutical group based in Lugano, and Vifor Pharma, are pleased to announce that a Distribution & Licensing Agreement for Helsinn's product Gelclair in Switzerland has been signed recently. ...

  • 23.04.2010 – 17:10

    Biodiversity Institute of Ontario - University of Guelph

    International Barcode of Life Project Gets Major Funding Boost in Lead-Up to Official Launch

    Guelph, Canada, April 23, 2010 (ots/PRNewswire) - The International Barcode of Life (iBOL) Secretariat today announced major new funding for the world's largest biodiversity genomics project. Paul Hebert, iBOL Scientific Director, said that four Canadian agencies have made new commitments totaling $35 million, raising total investments by these funders to $80 ...

  • 20.04.2010 – 14:41

    European Wind Energy Association (EWEA)

    Wind: 50% of EU Electricity in 2050

    Warsaw, Poland, April 20, 2010 (ots/PRNewswire) - Wind energy will meet 50% of the EU's electricity demand in 2050, top wind energy personalities told Europe's largest wind energy conference and exhibition. Topping the agenda at the opening day of the European Wind Energy Conference and Exhibition (EWEC 2010) in Warsaw was Europe's long-term energy supply. "2050 might seem like a long way off, but the decisions ...

  • 20.04.2010 – 07:03

    Astellas Pharma Europe Limited

    Urology and Transplantation Will Drive Future Growth as Astellas Begins Move into Oncology

    London, April 20, 2010 (ots/PRNewswire) - Today, on the fifth anniversary since its formation, Astellas Pharma Europe has confirmed that it will continue its emphasis on transplantation and urology while moving towards a new vision to build a strong presence in oncology. Astellas has shown robust growth since its creation, expanding its reach into new therapeutic ...

  • 19.04.2010 – 08:46

    Stallergenes

    Stallergenes: Positive Results for Oralair(R) Phase III Trial in the USA

    Antony, France, April 19, 2010 (ots/PRNewswire) - Stallergenes S.A. today announced the first results of a phase III clinical trial (VO61.08) conducted in the USA on its sublingual grass pollen immunotherapy tablet, Oralair(R). This phase III study is the first clinical study in the USA to be conducted by Stallergenes as part of the Oralair(R) ...

  • 19.04.2010 – 06:04

    Ivar Jacobson International

    Ivar Jacobson International Announces New Version of EssWork

    Stockholm, Sweden, April 19, 2010 (ots/PRNewswire) - Ivar Jacobson International today is releasing a new version of EssWork which provides a "smart" framework for developing, browsing and executing software development practices. New features in EssWork 3.0 enhance and simplify an organization's ability to roll-out large-scale agile software development by giving software teams process guidelines that efficiently ...

  • 16.04.2010 – 15:05

    Bank of America Corporation

    Bank of America Earns US$3.2 Billion in First Quarter

    Charlotte, April 16, 2010 (ots/PRNewswire) - Bank of America Corporation today reported first-quarter 2010 net income of US$3.2 billion compared with a net loss of US$194 million in the fourth quarter and net income of US$4.2 billion a year earlier. After preferred dividends, the company earned US$0.28 per diluted share in the first quarter, up from a loss of US$0.60 per share in the fourth quarter and earnings of ...